Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

OTC

Nutra Pharma selects Pickwick Capital Partners for strategic advisory services Nutra Pharma, a biotechnology company marketing Nyloxin and Pet Pain-Away in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced that they have engaged Pickwick Capital Partners; a leading investment banking, securities and investment management firm, to provide strategic corporate planning and investment banking services.
Production & Manufacturing > OTC > News
Medical Marijuana holds investment in AXIM Biotechnologies Medical Marijuana would like to inform the public and shareholders that it holds 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies (AXIM), a cutting-edge biotechnology innovator.
Production & Manufacturing > OTC > News Cosmederm Bioscience introduces two new steroid-free itch relief products By PBR Staff Writer
US-based pharmaceutical firm Cosmederm Bioscience has expanded its itch-relief product line, TriCalm, with the launch of TriCalm Clinical Repair Cream and TriCalm Extra Strength Spray.
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight

View all OTC news or find news targeted to your interests
Moberg Pharma to secure Eurostars grant of EUR0.9m
Moberg Pharma announced that a grant of EUR0.9m in public funding has been approved by Eurostars for a project proposal related to late-stage development of Moberg Pharma’s BUPI project.
Production & Manufacturing > OTC > News
Nutra Pharma expands production of Nyloxin
Nutra Pharma, a biotechnology company marketing Nyloxin and Pet Pain-Away in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced that they have completed a series of projects to update and expand the facilities that house the Asian cobras utilized for the production of Nyloxin.
Production & Manufacturing > OTC > News
Amphastar gets FDA approval for Amphadase to improve resorption of radiopaque agents
By PBR Staff Writer
Amphastar Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its new drug application (NDA) supplement for Amphadase (hyaluronidase injection).
Production & Manufacturing > OTC > News
SDC Nutrition continues to expand global presence with growth into Brazil
SDC Nutrition, a health supplement manufacturing and brand marketing company specializing in sports nutrition and health and wellness supplements announced their expansion into Brazil.
Production & Manufacturing > OTC > News
Startup Nutraceutical Wellness launches maiden hair health product
Nutraceutical Wellness announced the official launch of the company, a first of its kind wellness brand dedicated completely to helping consumers achieve healthy hair, using clinically proven ingredients.
Production & Manufacturing > OTC > News
GoodBelly intorduces new digestive supplements
GoodBelly, a line of delicious probiotic drinks formulated for daily digestive health, is now making it even easier for consumers to achieve optimum intestinal balance with the debut of its new probiotic capsule: GoodBelly Probiotic Supplement.
Production & Manufacturing > OTC > News
GAT introduces new formulations for JetFuel Superburn and T-300 Products
GAT, a leading manufacturer of sport nutrition products, announced a nationwide re-launch of two of its key brand franchises. The JetFuel Superburn and T-300 products have been reformulated using rigorously tested ingredients and manufactured in a cGMP certified facility.
Production & Manufacturing > OTC > News
Pfizer to expand caltrate and centrum production in China with new $95m production plant
By PBR Staff Writer
Pfizer has started construction of a new $95m production facility in Suzhou, China, to expand its production of Caltrate dietary supplements and Centrum multivitamins in the region.
Production & Manufacturing > OTC > News
New bill unveiled to make birth control pills available without prescription in US
By PBR Staff Writer
A new bill has been unveiled in the US to make birth control pills approved by the Food and Drug Administration, available without a prescription, to help expand women’s access to affordable contraceptives.
Production & Manufacturing > OTC > News
Convergence Point Media opens eHealthStore for ready-to-buy health consumers
By PBR Staff Writer
Convergence Point Media (CPM) has launched a mobile health shopper network, eHealthStore, to deliver convenience of online shopping with the ability to enable ready-to-buy health consumers to instantly find their product.
Production & Manufacturing > OTC > News
View all OTC news or find news targeted to your interests